Investor Reporting Concerns
MG Bradley, R D'Vari, M Olds - Journal of Structured Finance, 2013 - search.proquest.com
This panel discussed the challenges multiple parties have in collecting and using loan-level
data reported by servicers, lack of guidance on how servicers should treat loan modifications…
data reported by servicers, lack of guidance on how servicers should treat loan modifications…
[CITATION][C] Improvement in psoriasis is associated with long-term inhibition of radiographic progression in patients with psoriatic arthritis receiving adalimumab …
…, DD Gladman, P Mease, C Ritchlin, M Olds… - Arthritis & …, 2008 - kclpure.kcl.ac.uk
… Gladman, Philip Mease, Christopher Ritchlin, Michele Olds, Robert Wong, Shuhe Wang,
John Medich …
John Medich …
[BOOK][B] Factitious disorder imposed on another: Literature scan
M Carter, J Cording - 2021 - ir.canterbury.ac.nz
Purpose The purpose of this literature scan is to provide up-to-date information on what is
known about children and young people affected by Factitious Disorder Imposed on Another (…
known about children and young people affected by Factitious Disorder Imposed on Another (…
[PDF][PDF] Testing Lack-of-Fit of Generalized Linear Models via Laplace Approximation
DL Glab - 2012 - core.ac.uk
… In particular, I indebted to Michele Olds and John Wagaman–I probably would not have
been able to survive graduate school without their help and encouragement. …
been able to survive graduate school without their help and encouragement. …
Seasonal variation of serum 25-hydroxy-vitamin D in two captive eastern black rhinoceros (Diceros bicornis michaeli) housed in a North American Zoo
J Olds, W Oltman, AJ Makowski, H Householder… - Journal of zoo and …, 2018 - BioOne
Black rhinoceros ( Diceros bicornis spp.) are critically endangered species, with less than
65 individual animals housed in captivity within Association of Zoos and Aquariums-accredited …
65 individual animals housed in captivity within Association of Zoos and Aquariums-accredited …
Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
PJ Mease, P Ory, JT Sharp, CT Ritchlin… - Annals of the …, 2009 - ard.bmj.com
… The authors acknowledge the assistance of Marilyn Collicott and Carol Feige for study
logistics, Michele Olds for statistical support and Jennifer Dinelli for data management (all of …
logistics, Michele Olds for statistical support and Jennifer Dinelli for data management (all of …
[CITATION][C] Interim results from an open-label extension study of briakinumab for the treatment of moderate to severe psoriasis
…, D Williams, K Papp, M Olds - JOURNAL OF …, 2012 - … , NEW YORK, NY 10010-1710 USA
[CITATION][C] Short-and long-term briakinumab efficacy in moderate to severe psoriasis patients with prior TNF antagonist exposure: Subanalysis of a 52-week phase III …
K Papp, J Valdes, M Olds - JOURNAL OF …, 2012 - … , NEW YORK, NY 10010-1710 USA
[CITATION][C] Efficacy and safety of briakinumab for treatment of moderate to severe psoriasis in patients previously receiving etanercept: Results from an open-label …
…, DA Williams, M Olds - JOURNAL OF …, 2012 - … , NEW YORK, NY 10010-1710 USA
[CITATION][C] Efficacy and safety of briakinumab in moderate to severe psoriasis patients with prior failure to TNF antagonist: Subanalysis of a 52-week phase III trial and …
…, B Strober, D Williams, M Olds - JOURNAL OF …, 2012 - … , NEW YORK, NY 10010-1710 USA